PCD Pharma Franchise Opportunities in Himachal Pradesh with Daksh Diabetes and Cardiac Care
Recent data reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Himachal Pradesh. According to the Longitudinal Ageing Study in India (LASI 2017-18), 11.4% of men and 12.2% of women aged 45 and above have diabetes. The National Family Health Survey (NFHS-5) found that the diabetes prevalence in Himachal Pradesh is higher than the national average, with rates significantly elevated in urban areas.
The burden of hypertension is equally alarming. An ICMR study found that 16.7% of the population in Himachal Pradesh has raised blood pressure, with 35.3% in the pre-hypertension stage. This indicates a massive at-risk population that is on the verge of developing full-blown hypertension.
The primary drivers include the traditional Himachali diet—rich in high glycemic index foods like rice and wheat, high saturated fat from ghee and butter, and sugar-rich sweets—combined with sedentary occupations, stressful urban living in cities like Shimla, Solan, and Mandi, declining physical activity, and increased consumption of processed foods. A recent national survey found that 69% of households in Punjab, Haryana, and Himachal have members addicted to sugar or sugary products, making it the single biggest contributor to the diabetes epidemic. Additionally, fatty liver cases in Himachal Pradesh have increased by 40% in the last six months, with doctors attributing this to junk food and spicy food consumption, affecting even 10-year-old children. The state also has a high prevalence of hidden diabetes, with many cases going undiagnosed.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Himachal families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Himachal Pradesh
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Himachal patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Himachal Pradesh
Daksh works with hospitals, clinics, and pharmacies across Himachal Pradesh to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The pharma market in Himachal offers low investment (starting at ₹25,000) with high profit margins and monopoly rights in selected areas.
Popular Locations for PCD Pharma Franchise in Himachal Pradesh
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Baddi | Cardiac diabetic PCD company in Baddi |
| PCD pharma franchise in Solan | Cardiac diabetic products in Solan |
| PCD pharma franchise in Paonta Sahib | Diabetic cardiac PCD franchise in Paonta Sahib |
| PCD pharma franchise in Shimla | Cardiac diabetic PCD company in Shimla |
| PCD pharma franchise in Mandi | Cardiac diabetic products in Mandi |
| PCD pharma franchise in Kangra | Diabetic cardiac PCD franchise in Kangra |
| PCD pharma franchise in Una | Cardiac diabetic PCD company in Una |
| PCD pharma franchise in Hamirpur | Cardiac diabetic products in Hamirpur |
| PCD pharma franchise in Kullu | Diabetic cardiac PCD franchise in Kullu |
| PCD pharma franchise in Chamba | Cardiac diabetic PCD company in Chamba |
Conclusion
The diabetes and heart disease epidemic in Himachal Pradesh is not just a statistic—it is a reality affecting thousands of families. With the state recording a diabetes prevalence of 11.4% among men and 12.2% among women aged 45+ , pre-hypertension affecting 35.3% , and 40% increase in fatty liver cases, the burden is already immense and growing . But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |